PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Similar documents
Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

DP Fusidic Acid Cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Retin-A 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

Daktacort 2% / 1% w/w cream

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Eumovate Ointment clobetasone butyrate

Eumovate Cream clobetasone butyrate

Package Leaflet: Information for the User

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

ACETOCAUSTIN 0,5 ml, Cutaneous solution

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

ISOTREX GEL Isotretinoin 0.05% w/w

Dermovate Scalp Application clobetasol propionate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Dermovate Ointment clobetasol propionate

1 What Gyno-Daktarin cream is and what it is used for

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

PATIENT INFORMATION LEAFLET. Timodine Cream

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Dermovate Scalp Application clobetasol propionate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

What is in this leaflet 1. What Dalacin Cream is and what it is used for

SIGMACORT cream and ointment

Occlusal 26%w/w cutaneous solution salicylic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

O N C E A DAY. In this leaflet FOR WOMEN

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Hair Loss Treatment Regular Strength (Minoxidil)

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Dermovate Ointment clobetasol propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

WOMEN'S Regaine EXTRA STRENGTH

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

v MM 130.2MM FOR WOME N O N C E A D AY

CONSUMER MEDICINE INFORMATION

EUMOVATE Clobetasone butyrate 0.05% w/w cream

Information PROPECIA Finasteride 1mg Tablet

regeneration of the skin barrier, helping your skin to heal and diminishing the urge to scratch.

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM EMOLLIENT. Light Liquid Paraffin Emollient

Ego DermAid 1% cream Hydrocortisone 1 % w/w

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

COPPERPEX STICK COPPERPEX SUN

A guide for patients who have been prescribed Stelara

COPPERPEX GEL. The product for lips with herpes TOPICAL USE. Medical Device

COSMETICS EUROPE: N 24B HAIR DYE LABELLING - INFORMATION FOR PROFESSIONALS

Skin Allergy Testing Information

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Always read the label. Use only as directed. If symptoms persist, see your Healthcare Professional. MUNDICARE, BURNAID and WOUNDAID are registered

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory DERMOCALM LOTION. Calamine and Light Liquid Paraffin Lotion

EMOLLIENTS. NEW 500g NEW. pump. Up to 37% Wider choice, greater savings! cost savings. without compromising on quality or patient care!

Dalacin V Cream Clindamycin phosphate

Professional Manicure & Pedicure Kit

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

INFORMATION ABOUT YOUR TREATMENT

Psoralen Tablets (Methoxypsoralen)

Daivobet 50/500 gel Dye-vo-bet

NUTRALUXE MD TRAINING MANUAL: NUTRALUXE EYES BY NUTRALUXE MD TOPICS BASIC ITEM INFORMATION PRODUCT SUMMARY ABOUT WHY BENEFITS WHAT TO EXPECT

Patient Information Leaflet. Dermal Filler

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

Scabies. Dr. Ghassan Salah

Instructions For Use

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

Scar management. Patient Information Service. Southend University Hospital NHS Foundation Trust. Rehabilitation department Hand therapy

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL CREAMY WASH. Benzoyl Peroxide Creamy Wash 4%

HAND DERMATITIS - HOW TO CARE FOR YOUR HANDS

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL HYDROPHASE. Benzoyl Peroxide Cream IP

Questions and answers on sodium laurilsulfate used as an excipient in medicinal products for human use

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Table of Contents. Adult CPR Infant CPR Caring for a cut Burn Care Use of Epi Pen

ACCUTANE TO STOP OILY SKIN

Transcription:

PACKAGE LEAFLET EN Elastoplast Heat Plaster 11 mg January 2013 1

Package leaflet: Information for the user Elastoplast Heat Plaster11 mg medicated Plaster Soft extract of cayenne pepper (equiv. to 11 mg Capsaicin) Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. - You must talk to a doctor if you do not feel better or if you feel worse after 3 weeks. What is in this leaflet 1. What Elastoplast Heat Plaster is and what it is used for 2. What you need to know before you use Elastoplast Heat Plaster 3. How to use Elastoplast Heat Plaster 4. Possible side effects 6. Contents of the pack and other information 1. What Elastoplast Heat Plaster is and what it is used for Elastoplast Heat Plaster is used externally for the relief of muscle pain, e.g. lower back pain of adults and adolescents above the age of 12. 2. What you need to know before you use Elastoplast Heat Plaster Do not use Elastoplast Heat Plaster - if you are allergic to cayenne pepper, to other capsaicinoid sources (e.g. paprika plants) or any of the other ingredients of this medicine (listed in section 6). - on broken skin, wounds and eczema. Warnings and precautions Talk to your doctor or pharmacist before using Elastoplast Heat Plaster - in those more serious cases when your condition is accompanied by reddening, swelling or a feeling of high temperature of the joints, - if you have ongoing joint trouble, - if you have severe back pain radiating into the legs and/or associated with neurological syndromes (e.g. numbness, tingling). In addition please observe the following: - Do not apply the plaster near the eyes, mouth, tongue or lips. - It is recommended not to scratch the application site to avoid damage to the skin (see also: "Do not use Elastoplast Heat Plaster ). - Avoid application of additional sources of heat during treatment. Treatment should be discontinued if excessive warmth is experienced.. Children EN Elastoplast Heat Plaster 11 mg January 2013 2

Because there is no experience available, use of this medicinal product is not recommended in children below the age of 12 years. Other medicines and Elastoplast Heat Plaster Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. - The plaster is not intended to be applied at the same time as other external products [e.g. other rubefacients (agents that redden the skin due to increased blood flow) or pain relieving gels] at the same application site. - Interactions with other medicinal products applied at the same application site may even occur up to 12 hours after the plaster has been removed. Pregnancy and breast-feeding Do not use the plaster if you are pregnant, planning to be pregnant or breastfeeding without first consulting your doctor. The active substance of the plaster (soft extract of cayenne pepper) may pass into breast milk. Driving and using machines There is no reason to believe that the use of Elastoplast Heat Plaster will impair the ability to drive or use machines. Elastoplast Heat Plaster contains wool fat This medicinal product contains wool fat (lanoline). Wool fat may cause local skin reactions (e.g. contact dermatitis). 3. How to use Elastoplast Heat Plaster Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. Dosage A maximum of 1 plaster per day should be used. Method of administration The plaster must only be used on dry, intact skin. Peel off the covering paper and apply the plaster over the painful area, with the adhesive side to the skin. The plaster should be left in place for at least 4 and up to 12 hours. To remove the plaster, raise one corner and carefully pull it off. Hands should be washed with soap and water after handling the plaster. Any remnants remaining on the skin after detachment of the plaster can be removed with vegetable oil, a moisturising cream or cold water. There should be an interval of at least 12 hours before a new plaster is applied on the same application area. Duration of treatment The treatment should be continued until the pain subsides, if necessary, up to 3 weeks. Please consult your doctor if symptoms persist. If you use more Elastoplast Heat Plaster than you should Overdose with this plaster is extremely unlikely. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects EN Elastoplast Heat Plaster 11 mg January 2013 3

Like all medicines, Elastoplast Heat Plaster can cause side effects, although not everybody gets them. The active ingredient of the plaster causes increased local blood circulation with marked reddening of the skin and a sensation of warmth. This reaction is part of the normal effect of the medicine and subsides as a rule within a short time after removal of the plaster. Rare side effects (may affect up to 1 in 1,000 people) Skin hypersensitivity (allergic reactions) with reddening, itching and blisters may occur at the administration site. If this occurs, the plaster should be removed and the treatment should be discontinued. If during the first few days of treatment a burning sensation or any stinging or itching occurs which is too excessive, the plaster should be removed and the treatment should be discontinued. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Keep out of the sight and reach of children. After removal the plaster should be placed in a plastic bag, which is to be sealed securely and disposed of via household waste. Hands should be washed with soap and water after handling the plaster. Contact with the eyes, mouth, tongue or lips must be avoided. Do not use this medicinal product after the expiry date which is stated on the carton box. The expiry date refers to the last day of that month. Do not store above 25 C. After first opening of the package use within 3 months. What Elastoplast Heat Plaster contains The active substance is: Soft extract of cayenne pepper. Each medicated plaster contains 395.4 551.7 mg soft extract of cayenne pepper (4-7:1) which is equivalent to 11 mg capsaicinoids, calculated as capsaicin. Extract solvent is ethanol 80% (v/v). The other ingredients are: Liquid glucose; 2,2'-methylene-bis-(6-tert.-butyl-4-methylphenol); 2,2'-(propane-1,2- diyldiiminodimethyl) diphenol; orris root powder/rice flour mixture; caoutchouc; poly(butadieneblock-styrene) (76.5:23.5); cis-1,4-polyisoprene; talcum; beta-pinene; copolymer of 2-methylbut-2-ene and piperylene; glycerol ester of hydrogenated colophony; light liquid paraffin; wool fat; elastic flannel (adhesive carrier); paper siliconised on one side (covering paper). What Elastoplast Heat Plaster looks like and contents of the pack Elastoplast Heat Plaster is a rectangular perforated plaster (22cm x 14cm) with elastic flannel carrier. It is available in a pack with 1 or 2 medicated plasters. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer EN Elastoplast Heat Plaster 11 mg January 2013 4

Beiersdorf AG 20245 Hamburg Germany This medicinal product is authorised in the Member States of the EEA under the following names: {Name of Member State}{Name of the medicinal product} This leaflet was last updated in {MM/YYYY} EN Elastoplast Heat Plaster 11 mg January 2013 5